clomipramine has been researched along with milnacipran in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briley, M; Moret, C | 1 |
| Koponen, H; Leinonen, E; Lepola, U; Mehtonen, OP; Rimon, R | 1 |
| Den Boer, JA; Steen, A | 1 |
| Bymaster, FP; Evans, DC; Hemrick-Luecke, SK; Koch, S; Nelson, DL; Perry, KW; Thompson, LK; Threlkeld, PG | 1 |
| Courteix, C; Eschalier, A; Fialip, J; Libert, F; Loiodice, S; Privat, AM; Wattiez, AS | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for clomipramine and milnacipran
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for clomipramine and milnacipran
| Article | Year |
|---|---|
Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clomipramine; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Humans; Hypotension, Orthostatic; Male; Milnacipran; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Xerostomia | 1997 |
A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Constipation; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors | 1997 |
4 other study(ies) available for clomipramine and milnacipran
| Article | Year |
|---|---|
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Biogenic Monoamines; Brain Chemistry; Carrier Proteins; Clomipramine; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Extracellular Space; In Vitro Techniques; Male; Microdialysis; Milnacipran; Norepinephrine; p-Chloroamphetamine; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?
Topics: Analgesics; Animals; Antidepressive Agents; Clomipramine; Cyclopropanes; Diabetes Mellitus, Experimental; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Milnacipran; Naloxone; Neuralgia; Rats; Rats, Sprague-Dawley; Thiophenes | 2011 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |